Dr Oliver Bartley
BSc PhD
Cydymaith Ymchwil
Ysgol y Biowyddorau
- BartleyOJ@caerdydd.ac.uk
- +44 29208 79352
- Adeilad Syr Martin Evans, Rhodfa'r Amgueddfa, Caerdydd, CF10 3AX
Cyhoeddiad
2024
- Hennegan, J. et al. 2024. Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron development. iScience 27(1), article number: 108670. (10.1016/j.isci.2023.108670)
2022
- Jareno, P. G., Bartley, O., Precious, S., Rosser, A. and Lelos, M. 2022. Challenges in progressing cell therapies to the clinic for Huntington's disease: A review of the progress made with pluripotent stem cell derived medium spiny neurons. In: International Review of Neurobiology: Current Challenges in Cell Therapy for Neurodegenerative Diseases., Vol. 166. Elsevier, pp. 1-48., (10.1016/bs.irn.2022.09.003)
2021
- Bartley, O. J. M., Lelos, M. J., Gray, W. P. and Rosser, A. E. 2021. Do foetal transplant studies continue to be justified in Huntington's disease?. Neuronal Signaling 5, article number: acerbic. (10.1042/NS20210019)
- Rizzo, S. A., Bartley, O., Rosser, A. E. and Newland, B. 2021. Oxygen-glucose deprivation in neurons: implications for cell transplantation therapies. Progress in Neurobiology 205, article number: 102126. (10.1016/j.pneurobio.2021.102126)
- Choompoo, N. et al. 2021. Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease. Cytotherapy 23(2), pp. 111-118. (10.1016/j.jcyt.2020.06.001)
2019
- Bartley, O. J. M. 2019. Does epigenetic memory influence the differentiation of MSNs from fetal ganglionic eminence derived iPS cells?. PhD Thesis, Cardiff University.
Articles
- Hennegan, J. et al. 2024. Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron development. iScience 27(1), article number: 108670. (10.1016/j.isci.2023.108670)
- Bartley, O. J. M., Lelos, M. J., Gray, W. P. and Rosser, A. E. 2021. Do foetal transplant studies continue to be justified in Huntington's disease?. Neuronal Signaling 5, article number: acerbic. (10.1042/NS20210019)
- Rizzo, S. A., Bartley, O., Rosser, A. E. and Newland, B. 2021. Oxygen-glucose deprivation in neurons: implications for cell transplantation therapies. Progress in Neurobiology 205, article number: 102126. (10.1016/j.pneurobio.2021.102126)
- Choompoo, N. et al. 2021. Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease. Cytotherapy 23(2), pp. 111-118. (10.1016/j.jcyt.2020.06.001)
Book sections
- Jareno, P. G., Bartley, O., Precious, S., Rosser, A. and Lelos, M. 2022. Challenges in progressing cell therapies to the clinic for Huntington's disease: A review of the progress made with pluripotent stem cell derived medium spiny neurons. In: International Review of Neurobiology: Current Challenges in Cell Therapy for Neurodegenerative Diseases., Vol. 166. Elsevier, pp. 1-48., (10.1016/bs.irn.2022.09.003)
Thesis
- Bartley, O. J. M. 2019. Does epigenetic memory influence the differentiation of MSNs from fetal ganglionic eminence derived iPS cells?. PhD Thesis, Cardiff University.
Themâu ymchwil
Arbenigeddau
- Meddygaeth adfywiol
- Clefyd Huntington
- Bioleg Celloedd